Candida parapsilosis

The Candida parapsilosis home test detects and identifies the yeast Candida parapsilosis from clinical specimens (vaginal or genital swabs, urine, skin/nail scrapings or catheter-related samples) using culture and/or molecular methods performed by a UAE‑certified laboratory. Species‑level identification is important because different Candida species can vary in their susceptibility to antifungal drugs and in their tendency to cause superficial versus invasive infections. This test offers discreet sample collection at home with secure transport to the lab and fast, clinician‑ready results.

This service is primarily used to confirm a Candida parapsilosis infection in people with symptoms such as persistent vaginal itching, abnormal discharge, recurrent urinary symptoms, or wound/site infections associated with indwelling devices. It is also recommended for individuals with recurrent candidiasis, recent antibiotic use, diabetes, or weakened immunity where targeted therapy and antifungal susceptibility information can change treatment choice. Results support safer, evidence‑based prescriptions and reduce unnecessary empirical antifungal use.

For home collection, clear instructions are provided for proper swab or urine sampling and for preserving specimen integrity during transport to the UAE‑accredited laboratory; results are usually delivered electronically within the stated turnaround time and include species identification and, where available, antifungal susceptibility. Avoid topical or systemic antifungal treatment for 48–72 hours before sampling if clinically safe, and consult a physician to interpret results and determine appropriate treatment—Touch Connect can facilitate follow‑up with qualified UAE clinicians if required.

• Candida parapsilosis (presence/absence)
• Species identification
• Quantitative fungal load (CFU/ml or semi‑quantitative)
• Antifungal susceptibility profile
• Sample type confirmation (swab/urine/skin)

• Persistent vaginal itching, burning or abnormal discharge
• Recurrent vulvovaginal candidiasis despite treatment
• Urinary symptoms not responding to antibiotics
• Recent antibiotic use or immunosuppression with new symptoms
• Suspected catheter‑related or wound infection

• Discreet home sample collection by trained phlebotomist/technician
• UAE‑certified laboratory species identification and reporting
• Antifungal susceptibility to guide targeted therapy
• Fast, secure electronic results and clinician‑ready report
• Option for follow‑up consultation with a UAE healthcare provider

• Avoid topical or oral antifungals for 48–72 hours before sampling
• Do not have sexual intercourse for 24 hours prior to genital swab
• Collect sample when not actively menstruating if possible
• Patient identification and consent required; service available across Dubai (home collection fees may apply in AED)